JND-3229

N/A

Report date: 2023/03/31 16:32:06
NME

Base Information

Drug NameJND-3229
Drug Alias NameJND-3229
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR C797S inhibitors
TargetsEGFR C797S
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJinan University
China Registration ClassN/A

Develop Information

Active CompaniesJinan University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A